DOI: 10.1055/s-00000077

Seminars in Thrombosis and Hemostasis

Ausgabe 02 · Volume 30 · April 2004 DOI: 10.1055/s-002-3340 Gene Therapy in Hemophilia A and B in Animals and Humans: Current Status and Perspective Editor in Chief Eberhard F Mammen M.D., Guest Editors Thierry VandenDriessche Ph.D. Marinee K.L. Chuah Ph.D.

Post-Test Questions

  • C-1

    TUFTS UNIVERSITY SCHOOL OF MEDICINE OFFICE OF CONTINUING EDUCATION ACCREDITATION INFORMATION

    • PREFACE

  • 157
    Mammen, Eberhard F.:

    Gene Therapy in Hemophilia A and B

  • 161
    Couto, Linda B.:

    Preclinical Gene Therapy Studies for Hemophilia Using Adeno-Associated Virus (AAV) Vectors

  • 173
    Thorrez, Lieven; VandenDriessche, Thierry; Collen, Désiré; Chuah, Marinee K. L.:

    Preclinical Gene Therapy Studies for Hemophilia Using Adenoviral Vectors

  • 185
    Damme, An Van; Chuah, Marinee K. L.; Collen, Désiré; VandenDriessche, Thierry:

    Onco-Retroviral and Lentiviral Vector-Based Gene Therapy for Hemophilia: Preclinical Studies

  • 197
    Gómez-Vargas, Andrew; Hortelano, Gonzalo:

    Nonviral Gene Therapy Approaches to Hemophilia

  • 205
    Rawle, Fiona E. M.; Lillicrap, David:

    Preclinical Animal Models for Hemophilia Gene Therapy: Predictive Value and Limitations

  • 215
    Herzog, Roland W.; Dobrzynski, Eric:

    Immune Implications of Gene Therapy for Hemophilia

  • 227
    Pipe, Steven W.:

    Coagulation Factors with Improved Properties for Hemophilia Gene Therapy

  • 239
    Ragni, Margaret V.:

    Hemophilia Gene Transfer: Comparison with Conventional Protein Replacement Therapy

  • 249
    Collen, Désiré; VandenDriessche, Thierry; Chuah, Marinee K. L.:

    Clinical Gene Transfer Studies for Hemophilia A

  • 257
    High, Katherine A.:

    Clinical Gene Transfer Studies for Hemophilia B